vs
Side-by-side financial comparison of Hyperscale Data, Inc. (GPUS) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $26.9M, roughly 1.0× Hyperscale Data, Inc.). Hyperscale Data, Inc. runs the higher net margin — -112.0% vs -147.1%, a 35.2% gap on every dollar of revenue. On growth, Hyperscale Data, Inc. posted the faster year-over-year revenue change (38.4% vs -67.6%).
Hyperscale Data, Inc. provides GPU-accelerated computing infrastructure and cloud solutions tailored for AI development, big data processing, and high-performance computing workloads. It primarily serves AI startups, large technology firms, and cloud service providers across North America and the Asia-Pacific region, delivering scalable, high-efficiency computing resources to support complex data processing needs.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
GPUS vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.9M | $28.1M |
| Net Profit | $-30.1M | $-41.3M |
| Gross Margin | 14.5% | — |
| Operating Margin | -117.8% | -147.6% |
| Net Margin | -112.0% | -147.1% |
| Revenue YoY | 38.4% | -67.6% |
| Net Profit YoY | -6670.3% | -182.8% |
| EPS (diluted) | — | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.9M | $28.1M | ||
| Q3 25 | $24.3M | $32.5M | ||
| Q2 25 | $25.9M | $15.7M | ||
| Q1 25 | $25.0M | $8.0M | ||
| Q4 24 | $19.4M | $86.6M | ||
| Q3 24 | $31.1M | $2.1M | ||
| Q2 24 | $17.8M | $500.0K | ||
| Q1 24 | $38.4M | $0 |
| Q4 25 | $-30.1M | $-41.3M | ||
| Q3 25 | $-13.0M | $-51.2M | ||
| Q2 25 | $-19.1M | $-44.9M | ||
| Q1 25 | $-4.2M | $-33.9M | ||
| Q4 24 | $-445.0K | $49.9M | ||
| Q3 24 | $-25.5M | $-19.1M | ||
| Q2 24 | $-33.9M | $-12.5M | ||
| Q1 24 | $3.7M | $-10.3M |
| Q4 25 | 14.5% | — | ||
| Q3 25 | 25.8% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 21.1% | — | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 27.5% | — | ||
| Q2 24 | -21.3% | — | ||
| Q1 24 | 47.4% | — |
| Q4 25 | -117.8% | -147.6% | ||
| Q3 25 | -57.8% | -163.7% | ||
| Q2 25 | -39.2% | -302.9% | ||
| Q1 25 | -25.5% | -466.3% | ||
| Q4 24 | -46.8% | 54.5% | ||
| Q3 24 | -79.2% | -1051.6% | ||
| Q2 24 | -151.4% | -3068.0% | ||
| Q1 24 | 9.5% | — |
| Q4 25 | -112.0% | -147.1% | ||
| Q3 25 | -53.5% | -157.4% | ||
| Q2 25 | -73.7% | -285.6% | ||
| Q1 25 | -16.8% | -425.7% | ||
| Q4 24 | -2.3% | 57.7% | ||
| Q3 24 | -82.3% | -925.0% | ||
| Q2 24 | -190.7% | -2503.2% | ||
| Q1 24 | 9.7% | — |
| Q4 25 | — | $-0.41 | ||
| Q3 25 | $-0.39 | $-0.52 | ||
| Q2 25 | $-2.66 | $-0.46 | ||
| Q1 25 | — | $-0.35 | ||
| Q4 24 | $-8.78 | $0.52 | ||
| Q3 24 | $-24.82 | $-0.20 | ||
| Q2 24 | $-37.81 | $-0.13 | ||
| Q1 24 | $3.32 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.1M | $245.0M |
| Total DebtLower is stronger | $83.1M | $96.4M |
| Stockholders' EquityBook value | $119.8M | $114.3M |
| Total Assets | $313.7M | $327.7M |
| Debt / EquityLower = less leverage | 0.69× | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.1M | $245.0M | ||
| Q3 25 | $24.8M | $288.2M | ||
| Q2 25 | $5.9M | $240.1M | ||
| Q1 25 | $4.2M | $275.7M | ||
| Q4 24 | $4.5M | $314.0M | ||
| Q3 24 | $7.9M | $204.6M | ||
| Q2 24 | $9.6M | $218.7M | ||
| Q1 24 | $18.9M | $223.6M |
| Q4 25 | $83.1M | $96.4M | ||
| Q3 25 | $80.0M | $96.2M | ||
| Q2 25 | $88.5M | — | ||
| Q1 25 | $92.8M | — | ||
| Q4 24 | $96.7M | $0 | ||
| Q3 24 | $104.8M | — | ||
| Q2 24 | $106.8M | — | ||
| Q1 24 | $30.0M | — |
| Q4 25 | $119.8M | $114.3M | ||
| Q3 25 | $55.9M | $147.7M | ||
| Q2 25 | $5.5M | $192.3M | ||
| Q1 25 | $6.3M | $229.0M | ||
| Q4 24 | $8.6M | $256.8M | ||
| Q3 24 | $2.7M | $201.0M | ||
| Q2 24 | $26.7M | $215.2M | ||
| Q1 24 | $59.0M | $223.9M |
| Q4 25 | $313.7M | $327.7M | ||
| Q3 25 | $242.4M | $372.8M | ||
| Q2 25 | $213.5M | $313.5M | ||
| Q1 25 | $218.5M | $327.3M | ||
| Q4 24 | $220.8M | $351.2M | ||
| Q3 24 | $231.5M | $217.6M | ||
| Q2 24 | $270.8M | $222.0M | ||
| Q1 24 | $299.8M | $227.6M |
| Q4 25 | 0.69× | 0.84× | ||
| Q3 25 | 1.43× | 0.65× | ||
| Q2 25 | 16.06× | — | ||
| Q1 25 | 14.71× | — | ||
| Q4 24 | 11.19× | 0.00× | ||
| Q3 24 | 38.41× | — | ||
| Q2 24 | 4.00× | — | ||
| Q1 24 | 0.51× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-37.7M | $-43.5M |
| Free Cash FlowOCF − Capex | $-56.2M | — |
| FCF MarginFCF / Revenue | -208.7% | — |
| Capex IntensityCapex / Revenue | 68.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-87.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-37.7M | $-43.5M | ||
| Q3 25 | $-17.8M | $-47.0M | ||
| Q2 25 | $-3.1M | $-39.6M | ||
| Q1 25 | $-4.0M | $-40.7M | ||
| Q4 24 | $-9.2M | $42.0M | ||
| Q3 24 | $3.7M | $-14.5M | ||
| Q2 24 | $-3.7M | $-7.3M | ||
| Q1 24 | $-10.2M | $-6.7M |
| Q4 25 | $-56.2M | — | ||
| Q3 25 | $-20.6M | $-47.2M | ||
| Q2 25 | $-3.5M | $-39.6M | ||
| Q1 25 | $-6.8M | $-40.8M | ||
| Q4 24 | $-9.3M | $41.7M | ||
| Q3 24 | $2.6M | $-14.6M | ||
| Q2 24 | $-5.9M | $-7.3M | ||
| Q1 24 | $-11.6M | $-6.8M |
| Q4 25 | -208.7% | — | ||
| Q3 25 | -84.5% | -145.4% | ||
| Q2 25 | -13.5% | -252.2% | ||
| Q1 25 | -27.3% | -512.1% | ||
| Q4 24 | -47.6% | 48.2% | ||
| Q3 24 | 8.4% | -706.3% | ||
| Q2 24 | -33.4% | -1463.4% | ||
| Q1 24 | -30.3% | — |
| Q4 25 | 68.6% | 0.0% | ||
| Q3 25 | 11.5% | 0.6% | ||
| Q2 25 | 1.5% | 0.3% | ||
| Q1 25 | 11.5% | 1.1% | ||
| Q4 24 | 0.3% | 0.3% | ||
| Q3 24 | 3.6% | 6.8% | ||
| Q2 24 | 12.6% | 7.6% | ||
| Q1 24 | 3.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GPUS
| Transferred Over Time | $10.4M | 39% |
| Revenue From Mined Crypto Assets At Sentinum Owned And Operated Facilities | $5.8M | 21% |
| Hotel And Real Estate Operations | $4.8M | 18% |
| Other | $4.0M | 15% |
| Turn On Green | $2.0M | 7% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
